$146.95
1.300.89%
At close: -
$146.95
0.000.00%
After Hours: Dec 24, 1:00 PM EDT
Comments
Loading...
Latest news for Repligen (NASDAQ:RGEN) Stock
Repligen Stock (NASDAQ: RGEN)
Categories: All
Tuesday, December 17, 2024
Thursday, November 14, 2024
Tuesday, November 12, 2024
- Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
- 10 Health Care Stocks Whale Activity In Today's Session
- Repligen Raises FY24 Adj EPS Guidance from $1...
- Repligen Raises FY24 GAAP EPS Guidance from $...
- Repligen shares are trading higher after the ...
- Repligen Q3 2024 Adj. EPS $0.43 Beats $0.33 E...
- Earnings Scheduled For November 12, 2024
Thursday, September 26, 2024
Wednesday, September 18, 2024
Tuesday, August 27, 2024
Friday, August 16, 2024
Monday, August 05, 2024
Wednesday, July 31, 2024
Tuesday, July 30, 2024
- Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Repligen Lowers Guidance On China Weakness, Analyst Expects
- Stephens & Co. Reiterates Overweight on Repli...
- PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
- Repligen shares are trading higher. The compa...
- Repligen Expects 2024 Revenues Of $620M-$635M...
- Repligen Q2 2024 Adj. EPS $0.33, Inline, Sale...